{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:24:01Z","timestamp":1791329041760,"version":"4.3.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:p>Polygonum cuspidatum (Huzhang, HZ) is one of the commonly used traditional Chinese medicines for treating gouty arthritis (GA), but the specific mechanism is not clear. This study employed network pharmacology and molecular docking techniques to examine the molecular mechanisms underlying the therapeutic effects of HZ on GA. The network pharmacology approach, including active ingredient and target screening, drug-compound-target-disease network construction, protein-protein interaction (PPI) networks, enrichment analysis, and molecular docking, was used to explore the mechanism of HZ against GA. Ten active ingredients of HZ were predicted to interact with 191 targets, 14 of which interact with GA targets. Network pharmacology showed that quercetin, physovenine, luteolin, and beta-sitosterol are the core components of HZ, and IL (interleukin)-1\u03b2, IL-6, and tumor necrosis factor (TNF) are the core therapeutic targets. The mechanism of HZ in GA treatment was shown to be related to the IL-17 signaling pathway, NOD-like receptor signaling pathway, and Toll-like receptor signaling pathway, and is involved in the inflammatory response, positive regulation of gene expression, cellular response to lipopolysaccharide, and other biological processes. Molecular docking showed that all four core compounds had good binding properties to IL-1\u03b2, with luteolin and beta-sitosterol showing better docking results than anakinra, suggesting that they could be used as natural IL-1\u03b2 inhibitors in further experimental studies. The mechanism of action of HZ against GA has multi-target and multi-pathway characteristics, which provides an important theoretical basis for the study of the active ingredients of HZ as natural IL-1\u03b2 inhibitors.<\/jats:p>","DOI":"10.1097\/md.0000000000034396","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T14:43:37Z","timestamp":1689950617000},"page":"e34396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Exploring the inhibition mechanism of interleukin-1-beta in gouty arthritis by polygonum cuspidatum using network pharmacology and molecular docking: A review"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiao","family":"Ge","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Intensive Care Union, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulu","family":"Fang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3735-6450","authenticated-orcid":false,"given":"Jiyong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260710","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.3390\/nu11122955","article-title":"Dietary interventions for gout and effect on cardiovascular risk factors: a systematic review.","volume":"11","author":"Vedder","year":"2019","journal-title":"Nutrients"},{"key":"R2-20260710","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors.","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R3-20260710","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-017-1416-8","article-title":"Gout and comorbidity: a nominal group study of people with gout.","volume":"19","author":"Singh","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R4-20260710","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-018-1596-x","article-title":"Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.","volume":"20","author":"Drivelegka","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R5-20260710","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jbspin.2016.10.004","article-title":"Severe gout: strategies and innovations for effective management.","volume":"84","author":"Pascual","year":"2017","journal-title":"Joint Bone Spine"},{"key":"R6-20260710","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-019-2011-y","article-title":"Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study.","volume":"21","author":"Rey","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R7-20260710","doi-asserted-by":"crossref","first-page":"112606","DOI":"10.1016\/j.jep.2020.112606","article-title":"Investigation of the mechanism of action of Porana sinensis Hemsl. against gout arthritis using network pharmacology and experimental validation.","volume":"252","author":"Du","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"R8-20260710","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10787-020-00694-7","article-title":"Better outcomes for patients with gout.","volume":"28","author":"Day","year":"2020","journal-title":"Inflammopharmacology"},{"key":"R10-20260710","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.abb.2019.06.010","article-title":"Chaetocin attenuates gout in mice through inhibiting HIF-1\u03b1 and NLRP3 inflammasome-dependent IL-1\u03b2 secretion in macrophages.","volume":"670","author":"Mian","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"R11-20260710","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"\u03b2-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep"},{"key":"R12-20260710","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semarthrit.2015.02.006","article-title":"Anakinra for the treatment of acute severe gout in critically ill patients.","volume":"45","author":"Thueringer","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R13-20260710","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1093\/rheumatology\/keab383","article-title":"Efficacy of subcutaneous tocilizumab in a patient with severe gout refractory to anakinra.","volume":"60","author":"Calvo-Aranda","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R14-20260710","doi-asserted-by":"crossref","first-page":"1089993","DOI":"10.3389\/fmed.2022.1089993","article-title":"Effectiveness and safety of anakinra in gouty arthritis: a case series and review of the literature.","volume":"9","author":"Jeria-Navarro","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R15-20260710","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"R16-20260710","doi-asserted-by":"crossref","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula.","volume":"309","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R17-20260710","doi-asserted-by":"crossref","first-page":"15290","DOI":"10.1038\/srep15290","article-title":"Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease.","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"R18-20260710","doi-asserted-by":"crossref","first-page":"103613","DOI":"10.1016\/j.jprot.2019.103613","article-title":"UniprotR: Retrieving and visualizing protein sequence and functional information from Universal Protein Resource (UniProt knowledgebase).","volume":"213","author":"Soudy","year":"2020","journal-title":"J Proteomics"},{"key":"R19-20260710","doi-asserted-by":"crossref","first-page":"bav028","DOI":"10.1093\/database\/bav028","article-title":"DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes.","volume":"2015","author":"Pi\u00f1ero","year":"2015","journal-title":"Database (Oxford)"},{"key":"R20-20260710","doi-asserted-by":"crossref","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","article-title":"OMIM.org: leveraging knowledge across phenotype-gene relationships.","volume":"47","author":"Amberger","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R21-20260710","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape Automation: empowering workflow-based network analysis.","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biol"},{"key":"R22-20260710","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets.","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R23-20260710","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"R24-20260710","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update.","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R25-20260710","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/bioinformatics\/btab813","article-title":"RCSB Protein Data Bank: improved annotation, search and visualization of membrane protein structures archived in the PDB.","volume":"38","author":"Bittrich","year":"2022","journal-title":"Bioinformatics"},{"key":"R26-20260710","doi-asserted-by":"crossref","first-page":"e83922","DOI":"10.1371\/journal.pone.0083922","article-title":"Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology.","volume":"8","author":"Hsin","year":"2013","journal-title":"PLoS One"},{"key":"R27-20260710","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41584-021-00725-9","article-title":"Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care.","volume":"18","author":"Choi","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R28-20260710","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2018.00399","article-title":"Purinergic regulation of neutrophil function.","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"key":"R29-20260710","doi-asserted-by":"crossref","first-page":"5851412","DOI":"10.1155\/2022\/5851412","article-title":"Tanshinone IIA improves acute gouty arthritis in rats through regulating neutrophil activation and the NLRP3 inflammasome.","volume":"2022","author":"Xu","year":"2022","journal-title":"Dis Markers"},{"issue":"suppl_1","key":"R30-20260710","first-page":"i12","article-title":"The role of IL-1 in gout: from bench to bedside.","volume":"57","author":"So","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R31-20260710","doi-asserted-by":"crossref","first-page":"109112","DOI":"10.1016\/j.intimp.2022.109112","article-title":"Study on the effect and mechanism of quercetin in treating gout arthritis.","volume":"111","author":"Feng","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R32-20260710","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.phymed.2018.02.002","article-title":"Luteolin-4\u2019-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models.","volume":"41","author":"Lin","year":"2018","journal-title":"Phytomedicine"},{"key":"R33-20260710","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jep.2012.06.012","article-title":"Pharmacological basis for use of Lychnophora trichocarpha in gouty arthritis: anti-hyperuricemic and anti-inflammatory effects of its extract, fraction and constituents.","volume":"142","author":"de Souza","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"R34-20260710","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: from discovery to targeting.","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol Med"},{"key":"R35-20260710","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbrc.2018.02.166","article-title":"Serum levels of IL-17 are elevated in patients with acute gouty arthritis.","volume":"497","author":"Liu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R36-20260710","doi-asserted-by":"crossref","first-page":"3908061","DOI":"10.1155\/2017\/3908061","article-title":"The role of IL-17 and related cytokines in inflammatory autoimmune diseases.","volume":"2017","author":"Kuwabara","year":"2017","journal-title":"Mediators Inflamm"},{"key":"R37-20260710","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-015-0344-z","article-title":"The role of IL-17 and Th17 lymphocytes in autoimmune diseases.","volume":"63","author":"Tabarkiewicz","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R38-20260710","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/ard-2022-222764","article-title":"Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment.","volume":"82","author":"Xu","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R39-20260710","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.apsb.2022.09.014","article-title":"Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases.","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"R40-20260710","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/13880209.2021.1979595","article-title":"Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4\/MyD88\/NF-\u03baB pathway.","volume":"59","author":"Sun","year":"2021","journal-title":"Pharm Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:17Z","timestamp":1783728017000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":39,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034396","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}